Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology

Kharkiv 61068

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Muscular Atrophy, Spinal

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed